Malignant Glioma
Showing 26 - 50 of 124
Malignant Glioma Trial in United States (PVSRIPO)
Active, not recruiting
- Malignant Glioma
- PVSRIPO
-
San Francisco, California
- +5 more
Jun 28, 2022
Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)
Not yet recruiting
- Malignant Glioma
- Glioblastoma
- hEGFRvIII-CD3 (BRiTE)
- Activated Cell Therapy
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)
Active, not recruiting
- Supratentorial Neoplasms, Malignant
- +6 more
- G207
-
Birmingham, Alabama
- +1 more
Jun 1, 2022
Malignant Glioma, Recurrent Glioblastoma Trial in Chicago (biological, other, procedure)
Completed
- Malignant Glioma
- Recurrent Glioblastoma
- Durvalumab
- +3 more
-
Chicago, IllinoisNorthwestern University
Mar 17, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Malignant Glioma Trial in Tampa, Columbus (Hypofractionated Stereotactic Irradiation, Nivolumab, Bevacizumab)
Active, not recruiting
- Malignant Glioma
- Hypofractionated Stereotactic Irradiation
- +3 more
-
Tampa, Florida
- +1 more
Mar 23, 2022
Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three
Recruiting
- Malignant Glioma
- D2C7-IT (6920 ng/mL via convection-enhanced delivery)
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 22, 2022
Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil
Active, not recruiting
- Glioblastoma
- +3 more
- sorafenib tosylate
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Mar 21, 2022
Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI Scanner
-
Miami, FloridaUniversity of Miami
Mar 15, 2022
Malignant Glioma Trial in Nashville (Bevacizumab, Temozolomide, Vitamin C)
Completed
- Malignant Glioma
- Bevacizumab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Mar 9, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,
Recruiting
- Glioblastoma Multiforme
- +4 more
- pp65-shLAMP DC with GM-CSF
- +4 more
-
Gainesville, Florida
- +2 more
Jan 6, 2022
Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)
Recruiting
- Recurrent Medulloblastoma
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jan 8, 2022
Malignant Glioma Trial in Paris (Surgery, radiotherapy)
Completed
- Malignant Glioma
- Surgery
- radiotherapy
-
Paris, FranceFlorence Laigle
Nov 26, 2021
Intractable Epilepsy, Malignant Glioma, Seizure Disorder Trial in Jacksonville (Anticonvulsant Agent, Perampanel,
Recruiting
- Intractable Epilepsy
- +2 more
- Anticonvulsant Agent
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 22, 2021
Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,
Completed
- Glioblastoma
- +5 more
- Mind-Body Intervention Procedure
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2021
Malignant Glioma, Recurrent Ependymoma Trial in Chicago, Boston (biological, drug, radiation)
Completed
- Malignant Glioma
- Recurrent Ependymoma
- AdV-tk
- +2 more
-
Chicago, Illinois
- +1 more
Oct 26, 2021
Glioma, Malignant Glioma, Recurrent Glioma Trial in Los Angeles (Biospecimen Collection, Diagnostic Imaging, Magnetic Resonance
Recruiting
- Glioma
- +3 more
- Biospecimen Collection
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 24, 2021
Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)
Completed
- Malignant Glioma
- Glioblastoma Multiforme
- Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
-
Ann Arbor, MichiganUniversity of Michigan Health System Department of Neurosurgery
Aug 25, 2021
Malignant Brain Tumor, Malignant Glioma Trial in Palo Alto (procedure, biological, drug, device)
Suspended
- Malignant Brain Neoplasm
- Malignant Glioma
- Near-Infrared Fluorescence Imaging
- +3 more
-
Palo Alto, CaliforniaStanford University School of Medicine
Aug 10, 2021
Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)
Recruiting
- Malignant Glioma
- Recurrent Glioma
- personalized vaccine
-
Beijing, Beijing, ChinaXuanwu Hospital, Capital Medical University
Jun 26, 2021
Quality of Life of Glioblastoma Treated With Tumor-Treating
Completed
- Malignant Glioma
- NovoTTF
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Jun 7, 2021